+987.9%
MRNA vs AME
+21.1%
+966.8%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | AME | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | -4.6% | +17.7% | +12.6% |
| 7D | +20.6% | -4.4% | +25.1% | +20.1% |
| 30D | +27.1% | -5.9% | +33.0% | +26.3% |
| 3M | +353.4% | -6.5% | +359.9% | +358.1% |
| 6M | +446.3% | +3.2% | +443.1% | +398.9% |
| YTD | +776.2% | +16.0% | +760.2% | +534.3% |
| 1Y | +987.9% | +20.4% | +967.5% | +638.0% |
| All | +987.9% | +21.1% | +966.8% | +638.0% |
Cumulative growth
Daily Returns
Daily percentage return beside AME.
Daily Out/Under-Performance
Portfolio return minus AME return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × AME return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded AME wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling